Effects of Linagliptin on Hypoglycemia :Hypoglycemic Clamp Test in Japanese T2DM Patients - Hypoglycemic Clamp Test in Japanese T2DM Patients

Kansai Electric Power Hospital0 sites35 target enrollmentJuly 1, 2014

Overview

No summary available.

Registry

who.int

Start Date

July 1, 2014

End Date

April 20, 2015

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•(1\)Patients with diabetes requiring insulin therapy (insulin intensive therapy, T1DM, etc) (2\)Patients currently treated with Insulin, DPP\-4inhibitor, GLP\-1 receptor agonist within 4 weeks and/or treated with Pioglitazon within 12weeks (3\)Patients currently treated with alpha blocker, beta blocker, selective serotonin reuptake inhibitors (4\)Patients with history of cerebrovascular and cardiovascular disease (5\)Patients with heart failure with NYHA I\-IV (6\)Patients with renal dysfunction (7\)Patients with severe hepatic dysfunction (8\)Patients with history of pancreatitis (9\)Patients with diabetic retinopathy (proliferative retinopathy, vitreous hemorrhage and more severe condition) (10\)Patients with autonomic neuropathy (11\)Patients with a history of surgery of gastrointestinal tract (12\)Patients with malignant tumor (13\)Patients with severe infection, in the perioperative period or with serious injury (14\)Excessive alcohol intake (15\)Patients with hemoglobin (Hb) \<13\.0g/dL(male), \<12\.5g/dL(female) (16\)Patients found ineligible as a study patient according to the discretion of the investigator or sub\-investigator (17\)Patients participating in other clinical studies (18\)Pregnant or possibly pregnant women (19\)Patients judged as inadequate to participate in present study by investigator or sub\-investigator